share_log

Sanofi (EPA:SAN) Stock Passes Below Two Hundred Day Moving Average of $86.52

Sanofi (EPA:SAN) Stock Passes Below Two Hundred Day Moving Average of $86.52

赛诺菲(EPA: SAN)股票跌破两百日移动平均线86.52美元
Defense World ·  2023/02/07 03:22

Sanofi (EPA:SAN – Get Rating) shares passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of €86.52 ($93.03) and traded as low as €82.25 ($88.44). Sanofi shares last traded at €85.14 ($91.55), with a volume of 4,394,526 shares traded.

赛诺菲(EPA: SAN — Get Rating)的股价在周一的交易中跌破了其200天移动平均线。该股的200天移动平均线为86.52欧元(93.03美元),交易价格低至82.25欧元(88.44美元)。赛诺菲股票最后一次交易价格为85.14欧元(合91.55美元),交易量为4,394,526股。

Sanofi Stock Down 0.3 %

赛诺菲股价下跌0.3%

The company's fifty day simple moving average is €89.56 and its two-hundred day simple moving average is €86.52.

该公司的五十天简单移动平均线为89.56欧元,其两百天简单移动平均线为86.52欧元。

Sanofi Company Profile

赛诺菲公司简介

(Get Rating)

(获取评分)

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products.

赛诺菲及其子公司在美国、欧洲和国际上从事治疗解决方案的研究、开发、制造和营销。它通过三个部门运营:制药、疫苗和消费者医疗保健。该公司提供专业护理产品,包括人类单克隆抗体;多发性硬化症、神经病学、其他炎症性疾病、免疫学、罕见疾病、肿瘤学和罕见血液疾病的产品;糖尿病药物;以及心血管和成熟处方产品。

Further Reading

进一步阅读

  • Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
  • Can Cummins Power To A New High?
  • How to Find Penny Stocks to Invest and Trade
  • ONSemi Is Marching Higher On Great Results
  • What Tyson Foods Q1 Means For Staples Stocks
  • Energizer Holdings Inc;失去电力还是在浪费购买时间?
  • 康明斯能否再创新高?
  • 如何寻找细价股进行投资和交易
  • OnSemi 凭借出色的成绩向前迈进
  • 泰森食品第一季度对斯台普斯股票意味着什么

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.

接收赛诺菲日报的新闻和评级 -在下面输入您的电子邮件地址,即可通过Marketbeat.com的免费每日电子邮件时事通讯接收赛诺菲及相关公司最新新闻和分析师评级的简明每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发